YU57602A - Pluraflavini i njihovi derivati, postupci njihovog dobijanja i upotrebe - Google Patents

Pluraflavini i njihovi derivati, postupci njihovog dobijanja i upotrebe

Info

Publication number
YU57602A
YU57602A YU57602A YUP57602A YU57602A YU 57602 A YU57602 A YU 57602A YU 57602 A YU57602 A YU 57602A YU P57602 A YUP57602 A YU P57602A YU 57602 A YU57602 A YU 57602A
Authority
YU
Yugoslavia
Prior art keywords
alkynyl
alkenyl
alkyl
preparation
sugar
Prior art date
Application number
YU57602A
Other languages
English (en)
Inventor
Laszlo Vertesy
Klaus Ehrlich
Martin Knauf
Joachim Wink
Francis P. Barbone
Elaine A. Powers
Elizabeth A. Cashman
Original Assignee
Aventis Pharma Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of YU57602A publication Critical patent/YU57602A/sh
Publication of RS49991B publication Critical patent/RS49991B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/58Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ovaj pronalazak se odnosi na jedinjenje formule (I) gde je R1 secer; R2 je -CH2-O-(R7)m, R7 perdstavlja secer ili je R2-COOH; R3 je grupa koja sadrzi epoksid, C1-C6-alkil ili C2-C6-alkenil, nesupstituisan ili supstituisan sa najmanje jednim OH; R5 je H, C1-C6-alkil, C2-C6-alkenil ili C2-C6-alkinil; R4, R6, R8 i R10 svaki nezavisno, su H, C1-C6-alkil, C2-C6-alkenil, C2-C6-alkinil, -X2H i X2R12 ili R4 i R6 zajedno i/ili R8 i R10 zajedno, su X2; X2 je O, NH, N-C1-C6-alkil, N- C2-C6-alkenil, N- C2-C6-alkinil ili S; R12 je C1-C6-alkil, C2-C6-alkenil, C2-C6-alkinil, aril ili acil; i m i n su 1 ili 2; i njihove fizioloski prihvatljive soli. Ova jedinjenja se dobijaju fermentacijom kulture mikroorganizma Actinomycetes species HAG 009359, DSM 12931. U skladu sa tim ovaj pronalazak se odnosi na postupak za njihovo dobijanje i upotrebu ovih jedinjenja kao faramceutskih proizvoda, na primer anti-tumorskih agenasa.
YUP-576/02A 2000-02-18 2001-02-15 Pluraflavini i njihovi derivati, postupci njihovog dobijanja i upotrebe RS49991B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00103540A EP1125944A1 (de) 2000-02-18 2000-02-18 Pluraflavine und Derivate davon, Verfahren zu ihrer Herstellung und Verwendung derselben

Publications (2)

Publication Number Publication Date
YU57602A true YU57602A (sh) 2005-11-28
RS49991B RS49991B (sr) 2008-09-29

Family

ID=8167898

Country Status (31)

Country Link
US (1) US6500936B2 (sh)
EP (2) EP1125944A1 (sh)
JP (1) JP4801307B2 (sh)
KR (1) KR100743380B1 (sh)
CN (1) CN1162441C (sh)
AR (1) AR027436A1 (sh)
AT (1) ATE255120T1 (sh)
AU (2) AU2001242404B2 (sh)
BR (1) BR0108128A (sh)
CA (1) CA2400237C (sh)
CZ (1) CZ303810B6 (sh)
DE (1) DE60101313T2 (sh)
DK (1) DK1259523T3 (sh)
EE (1) EE05137B1 (sh)
ES (1) ES2207609T3 (sh)
HK (1) HK1052709B (sh)
HR (1) HRP20020672B1 (sh)
HU (1) HU228332B1 (sh)
IL (2) IL151216A0 (sh)
ME (1) ME00179B (sh)
MX (1) MXPA02006919A (sh)
NO (1) NO323413B1 (sh)
PL (1) PL204842B1 (sh)
PT (1) PT1259523E (sh)
RS (1) RS49991B (sh)
RU (1) RU2255940C2 (sh)
SI (1) SI1259523T1 (sh)
SK (1) SK286691B6 (sh)
TR (1) TR200302180T4 (sh)
WO (1) WO2001060832A2 (sh)
ZA (1) ZA200206795B (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
CN101921300B (zh) * 2009-06-10 2014-04-02 上海来益生物药物研究开发中心有限责任公司 一种异黄酮苷类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274545B1 (en) * 1986-07-21 1992-12-02 Kyowa Hakko Kogyo Co., Ltd. Novel substances dc-92b and dc-92d, and process for their preparation
WO1990000935A1 (en) * 1988-07-22 1990-02-08 Masco Corporation Of Indiana A small hand-held shower head for domestic sinks connected to a faucet
US5001058A (en) * 1988-09-19 1991-03-19 Bristol-Myers Company BU-3839T antibiotic
PT93070A (pt) * 1989-02-07 1990-08-31 Abbott Lab Processo de preparacao de altromicinas e de composicoes farmaceuticas que as contem
US5168100A (en) * 1990-03-16 1992-12-01 Sapporo Breweries Limited Hp530 compounds and process for preparing the same
CA2778804C (en) * 2007-07-06 2015-12-22 Rite-Hite Holding Corporation Retractable safety barriers and methods of operating same

Also Published As

Publication number Publication date
PT1259523E (pt) 2004-04-30
WO2001060832A2 (en) 2001-08-23
DK1259523T3 (da) 2004-03-22
EP1125944A1 (de) 2001-08-22
IL151216A0 (en) 2003-04-10
TR200302180T4 (tr) 2004-03-22
EE05137B1 (et) 2009-02-16
HRP20020672A2 (en) 2004-12-31
KR100743380B1 (ko) 2007-07-30
MXPA02006919A (es) 2004-04-05
HK1052709A1 (en) 2003-11-21
RS49991B (sr) 2008-09-29
JP4801307B2 (ja) 2011-10-26
SK286691B6 (sk) 2009-03-05
NO20023845L (no) 2002-10-10
RU2002124772A (ru) 2004-02-20
EP1259523A2 (en) 2002-11-27
ES2207609T3 (es) 2004-06-01
NO323413B1 (no) 2007-04-30
DE60101313T2 (de) 2004-09-30
CA2400237C (en) 2008-12-30
HU228332B1 (en) 2013-03-28
AR027436A1 (es) 2003-03-26
RU2255940C2 (ru) 2005-07-10
HK1052709B (zh) 2005-02-04
ME00179B (me) 2011-02-10
HUP0204393A2 (hu) 2003-07-28
US20020028921A1 (en) 2002-03-07
WO2001060832A3 (en) 2002-01-31
SI1259523T1 (en) 2004-04-30
CZ20022826A3 (cs) 2002-11-13
HUP0204393A3 (en) 2007-10-29
CN1404484A (zh) 2003-03-19
US6500936B2 (en) 2002-12-31
CN1162441C (zh) 2004-08-18
AU4240401A (en) 2001-08-27
ATE255120T1 (de) 2003-12-15
CA2400237A1 (en) 2001-08-23
JP2003523346A (ja) 2003-08-05
EE200200438A (et) 2003-12-15
CZ303810B6 (cs) 2013-05-15
PL204842B1 (pl) 2010-02-26
PL358297A1 (en) 2004-08-09
BR0108128A (pt) 2003-02-25
IL151216A (en) 2009-12-24
AU2001242404B2 (en) 2005-04-14
NO20023845D0 (no) 2002-08-14
KR20020086539A (ko) 2002-11-18
ZA200206795B (en) 2003-11-19
HRP20020672B1 (en) 2010-12-31
DE60101313D1 (de) 2004-01-08
EP1259523B1 (en) 2003-11-26
SK11802002A3 (sk) 2003-02-04
MEP28608A (en) 2010-10-10

Similar Documents

Publication Publication Date Title
PL293795A1 (en) Method of obtaining cyclic urea derivatives
GB9108307D0 (en) Autoinducer
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
BG104913A (en) 15-membered lactams ketolides with antibacterial activity
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
WO2003082864A3 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
ES2178301T3 (es) Derivados del acido penicilanico 2-beta-sustituido-6-alquilideno como inhibidores de la beta-lactama.
SI1102765T1 (en) PROCESS FOR THE SYNTHESIS OF (1$i(H))-BENZO C)QUINOLIZIN-3-ONES DERIVATIVES
MXPA02006919A (es) Pluraflavinas y sus derivados, proceso para su preparacion y uso.
ES8206462A1 (es) Un metodo para preparar derivados de 2-oxoazetidina.
CA2092919A1 (en) Epoxysuccinamic acid derivatives
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
CA2430827A1 (en) Coniosetin and derivatives thereof, process for the preparation and the use thereof
AP2002002494A0 (en) Hygromycin derivatives.
HK1043597A1 (en) Novel derivatives from the class of oleandomycin
ATE259800T1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
NO20020886L (no) Nye integrin- <alfa>v<beta>3-inhibitorer
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
EA199900589A1 (ru) Производные эритромицина, способ их получения и их применение в качестве лекарственных средств
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.
DE50313293D1 (de) Polyencarbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung
MX9801664A (es) Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas.
JPS56133260A (en) Azetidine derivative and its preparation